Efficacy of Brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients

BACKGROUND: Allogeneic hematopoietic cell transplant (HCT) recipients are at risk for herpes simplex virus (HSV) and varicella-zoster virus (VZV) infections. Routine prophylaxis with acyclovir is recommended during periods of immunosuppression. Brincidofovir (BCV, CMX001), a lipid conjugate of cidof...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Transpl Infect Dis
Egile Nagusiak: Lee, Yeon Joo, Neofytos, Dionysios, Kim, Seong Jin, Cheteyan, Leslie, Huang, Yao-Ting, Papadopoulos, Esperanza B., Jakubowski, Ann A., Papanicolaou, Genovefa A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6310478/
https://ncbi.nlm.nih.gov/pubmed/30120866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tid.12977
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak